Michael Cruz Email and Phone Number
Washington, DC, US
Michael Cruz's Location
Washington DC-Baltimore Area, United States, United States
Michael Cruz's Contact Details
Michael Cruz work email
- Valid
- Valid
- Valid
- Valid
Michael Cruz personal email
n/a
Michael Cruz phone numbers
About Michael Cruz
Innovative, energetic, and solution-oriented. Passionate about science, particularly around Vaccine Development as a means to finding the next break-through medicine(s) for our future.
Michael Cruz's Current Company Details
Michael Cruz Work Experience Details
-
Sr. Director, Head Of Program Management, Infectious DiseaseModernaWashington, Dc, Us
-
Sr. Director, Head Of Program Management, Infectious DiseaseModerna Nov 2024 - PresentCambridge, Massachusetts, Us -
Sr. Director, Program Management Ta Lead, Respiratory VaccinesModerna Jun 2023 - Nov 2024Cambridge, Massachusetts, Us
-
Program Director, Covid-19 Program Management LeadModerna Jul 2021 - Jun 2023Cambridge, Massachusetts, UsProgram Director responsible for driving the COVID-19 mRNA portfolio to enable execution of the objectives and strategy of assigned developmental programs within the Respiratory Vaccines portfolio. Responsible for managing and supporting 6 program managers to end-end vaccine development including licensure across all age indications, next-generation COVID vaccine candidates, and emerging strategies for combination respiratory vaccines. As a member of the program management leadership team, my role includes shaping our portfolio, development strategies, key talent hiring, developing, and management/training of the Moderna's CDO program management team.
-
Program Management, Covid-19 & Influenza Vaccine DevelopmentPfizer Jul 2019 - Jun 2021New York, New York, UsCOVID-19 and Influenza Vaccine Development Program Manager for Vaccine R&D. I support the vaccine research and development (VRD) program teams in the development of new vaccines from research through product registration to ensure alignment of strategic and operational objectives. This includes developing program plans to support the overall strategy for the development of the vaccine in all indications.Key stakeholder management include partnering with Clinical, Vaccine Research, Early BioProcess Development, Pharmaceutical Sciences, Regulatory, Drug Safety, Commercial Development, Clinical Operations, etc. to manage the program to achieve key milestones within time, cost and quality parameters. -
Global Medical Affairs, ShingrixGsk Feb 2018 - May 2019Brentford, Middlesex, GbWorking on a one of a kind, novel vaccines for shingles. Managing and supporting launch of Herpes Zosters (Shingrix) in launch countries with a focus on coordination, development, and implementation of medical materials for training initiatives and scientific engagement activities. Supporting the global integrated congress plan and supporting GMA Directors and team with digital/social medical capabilities as a part of the global medical digital plan through customer insight gathered from Scientific Engagements field visits with Medical Scientific Liaison and external experts in Canada (MSL interactive tool pilot country) and in the US. Primarily responsible for the Zoster Clinical Compendium, the creation and implementation of the MSL iPad interactive tool, and the creation of a podcast series for the asset: Shingrix in the Mix. -
Future Leader Programme (Flp), Global Vaccines R&DGsk Sep 2016 - Sep 2018Brentford, Middlesex, GbGlaxoSmithKline's Future Leaders Program (FLP), is a program designated to cultivate & prepare the next generation of leaders. This two-year program comprises of three rotations within different R&D departments around the globe. I have been fortunate to work in two of the three GSK Global Vaccines Headquarters: Rixesensart, Belgium and Rockville, Maryland. My rotations included early asset Preclinical Viral and Parasites work on Dengue in Rixensart, Belgium; launch phase with the Global Neisseria Commercial & Marketing team on Meningococcal vaccines based out of Rockville, US; and launch phase with the Global Medical Affairs SHINGRIX team also in Rockville, Maryland, US.
-
Global Neisseria Marketing, Bexsero Brand ManagerGsk Sep 2017 - Feb 2018Brentford, Middlesex, GbCommercial associate working on a ~$1B dollar vaccine brand’s global commercialization team covering core markets. Responsible for performing epidemiological studies on Meningitis incidence in the UK before and after introduction of MenB vaccine (BEXSERO). Managed the co-creation with Porter Novelli UK agency of a World Meningitis Day focused disease awareness campaign with our high priority markets by working with industry leading external marketing advisors. Managed Brand Plan development and delivery of concepts with 3rd party agencies. My core tasks included enhancing existing multi-channel marketing capabilities including the creation of new branded materials, digital training aids, and assisting in analyzing customer segmentation to develop customer insights. Additionally, I worked to devise metrics to evaluate and measure our training materials’ effectiveness sand sales force performance through the Bexsero Veeva Dashboard. This innovative model pilotted for insights and metrics through the Dashboard framework has been adopted to other commercial vaccine brands.
-
Scientist, Preclinical Viruses (Dengue)Gsk Sep 2016 - Sep 2017Brentford, Middlesex, GbProjects: Dengue Vaccine Candidate (DPIV) -Developed a flow cytometry based assay to evaluate antibody cross neutralization induced by a current GSK dengue vaccine candidate in non-human primates. -Performed statistical and qualitative analysis for cytokine expression in a non-human primate experiment after primary DENV infection. -Establishment of the collaboration research agreement (CRA) with Felix Rey’s laboratory (Institut Pasteur, Paris) and Gavin Screaton’s laboratory (Imperial College, London): for new Dengue vaccine approach.Publications: Borges, M. B., Marchevsky, R. S., Cruz. M., Mendes, Y. S., Mendes, L. G., Duarte, A. C.., . Warter, L. (submitted). Detection of antibody-dependent enhancement of dengue infection in vaccinated macaques enabled early discontinuation of an inactivated and purified dengue virus vaccine candidate. Borges, M. B., Marchevsky, R. S., Mendes, Y. S., Mendes, L. G., Duarte, A. C., Cruz, M., . . . Warter, L. (2018). Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques. Plos One, 13(4). doi:10.1371/journal.pone.0196311
-
Research Associate I, SomUniversity Of Miami, Miller School Of Medicine Jul 2012 - Jul 2014Miami, Fl, UsAs part of Dr. David Watkins' lab, I studied the mechanisms of viral evasion in the immune system, and mapped epitopes to devise a T-cell response vaccine using yellow fever constructs and an RRV boost for treatment of SIV and dengue in Rhesus macaques under a BSL2+ laboratory. The importance of developing a T-cell based vaccine is to reduce viral peaks and induce viral control. Vaccine-induced T-cell responses against directed regions of SIV is thought to increase incidence in elite controlling of the virus. -
Emt-I89Emory Emergency Medical Services Aug 2011 - 2012Atlanta, Ga, UsEmory University student run volunteer service. -
Summer Intern: Research; Department Of Chemistry And Biochemistry: Florida InternatFlorida International University May 2011 - Aug 2011Miami, Fl, UsWe employed fluorescent conjugated polymer nanoparticles (CPNs) to deliever siRNAs and knockdown a target gene in plant protoplast. We demonstrated that CPNs could deliver siRNAs targeting specific genes in the cellulose biosynthesis pathways. The results lead to fluorescent conjugated polymers, which allowed for cell imaging and potential early cancer detection.
Michael Cruz Skills
Advance Professional S.c.u.b.a Diver
Scuba Diving
Rescue Diver
Lifeguarding
Red Cross Certified
Emt
Biochemistry
Cell
Research
Spanish
Fluorescence
Chemistry
Statistics
Stata
Laboratory
Michael Cruz Education Details
-
Drexel University College Of MedicineAnatomy And Physiology -
Emory UniversityBiology
-
Belen Jesuit Preparatory SchoolHigh School
Frequently Asked Questions about Michael Cruz
What company does Michael Cruz work for?
Michael Cruz works for Moderna
What is Michael Cruz's role at the current company?
Michael Cruz's current role is Sr. Director, Head of Program Management, Infectious Disease.
What is Michael Cruz's email address?
Michael Cruz's email address is mc****@****ami.edu
What is Michael Cruz's direct phone number?
Michael Cruz's direct phone number is +130572*****
What schools did Michael Cruz attend?
Michael Cruz attended Drexel University College Of Medicine, Emory University, Belen Jesuit Preparatory School.
What are some of Michael Cruz's interests?
Michael Cruz has interest in Epigenetics And Diseases, Academic, Church And State, Molecular And Cell Biology, Bioethics, Western Religion And Origins, Entrepreneurial Studies, Religion.
What skills is Michael Cruz known for?
Michael Cruz has skills like Advance Professional S.c.u.b.a Diver, Scuba Diving, Rescue Diver, Lifeguarding, Red Cross Certified, Emt, Biochemistry, Cell, Research, Spanish, Fluorescence, Chemistry.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial